Free Trial

Willis Towers Watson Public (NASDAQ:WTW) Price Target Raised to $334.00

Willis Towers Watson Public logo with Finance background

Willis Towers Watson Public (NASDAQ:WTW - Get Free Report) had its target price boosted by investment analysts at Wells Fargo & Company from $321.00 to $334.00 in a report issued on Thursday, Benzinga reports. The firm currently has an "overweight" rating on the stock. Wells Fargo & Company's price objective would suggest a potential upside of 14.94% from the company's previous close.

WTW has been the subject of several other reports. Keefe, Bruyette & Woods upped their price objective on shares of Willis Towers Watson Public from $320.00 to $323.00 and gave the company an "outperform" rating in a research note on Wednesday, July 31st. Roth Mkm upped their price target on Willis Towers Watson Public from $315.00 to $345.00 and gave the company a "buy" rating in a research report on Wednesday. Barclays assumed coverage on Willis Towers Watson Public in a research report on Wednesday, September 4th. They issued an "underweight" rating and a $278.00 price objective on the stock. Truist Financial upped their target price on Willis Towers Watson Public from $335.00 to $365.00 and gave the company a "buy" rating in a report on Wednesday. Finally, Morgan Stanley dropped their price target on Willis Towers Watson Public from $275.00 to $272.00 and set an "equal weight" rating for the company in a research note on Wednesday, July 10th. One research analyst has rated the stock with a sell rating, seven have given a hold rating and eight have given a buy rating to the stock. According to MarketBeat, the company has an average rating of "Hold" and an average target price of $303.60.

Read Our Latest Stock Report on WTW

Willis Towers Watson Public Price Performance

WTW traded down $4.82 during trading on Thursday, reaching $290.59. The stock had a trading volume of 663,915 shares, compared to its average volume of 460,002. The business has a 50-day moving average of $286.48 and a 200-day moving average of $269.72. Willis Towers Watson Public has a one year low of $203.36 and a one year high of $303.42. The company has a debt-to-equity ratio of 0.56, a quick ratio of 1.94 and a current ratio of 1.94. The stock has a market cap of $29.51 billion, a PE ratio of 29.20, a PEG ratio of 1.52 and a beta of 0.74.

Willis Towers Watson Public (NASDAQ:WTW - Get Free Report) last announced its quarterly earnings data on Thursday, July 25th. The company reported $2.55 earnings per share for the quarter, topping analysts' consensus estimates of $2.28 by $0.27. The firm had revenue of $2.27 billion during the quarter, compared to analyst estimates of $2.27 billion. Willis Towers Watson Public had a net margin of 11.24% and a return on equity of 16.97%. The business's quarterly revenue was up 4.9% on a year-over-year basis. During the same period in the previous year, the business posted $2.05 EPS. As a group, equities research analysts anticipate that Willis Towers Watson Public will post 16.51 EPS for the current fiscal year.

Institutional Trading of Willis Towers Watson Public

Hedge funds have recently bought and sold shares of the company. Richardson Financial Services Inc. bought a new position in Willis Towers Watson Public in the first quarter worth approximately $28,000. American National Bank bought a new position in Willis Towers Watson Public in the 2nd quarter worth $36,000. Beacon Capital Management LLC lifted its position in Willis Towers Watson Public by 136.5% during the first quarter. Beacon Capital Management LLC now owns 175 shares of the company's stock valued at $48,000 after purchasing an additional 101 shares in the last quarter. New Millennium Group LLC bought a new stake in Willis Towers Watson Public during the second quarter valued at about $54,000. Finally, LRI Investments LLC bought a new position in shares of Willis Towers Watson Public in the first quarter worth about $58,000. Hedge funds and other institutional investors own 93.09% of the company's stock.

Willis Towers Watson Public Company Profile

(Get Free Report)

Willis Towers Watson Public Limited Company operates as an advisory, broking, and solutions company worldwide. It operates through two segments: Health, Wealth & Career and Risk & Broking. The company offers strategy and design consulting, plan management service and support, broking and administration services for health, wellbeing, and other group benefit program, including medical, dental, disability, life, voluntary benefits and other coverages; actuarial support, plan design, and administrative services for pension and retirement savings plans; retirement consulting services and solutions; and integrated solutions that consists of investment discretionary management, pension administration, core actuarial, and communication and change management assistance services.

See Also

Analyst Recommendations for Willis Towers Watson Public (NASDAQ:WTW)

→ Next opportunity for crypto millions (From Crypto 101 Media) (Ad)

Should you invest $1,000 in Willis Towers Watson Public right now?

Before you consider Willis Towers Watson Public, you'll want to hear this.

MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Willis Towers Watson Public wasn't on the list.

While Willis Towers Watson Public currently has a "Hold" rating among analysts, top-rated analysts believe these five stocks are better buys.

View The Five Stocks Here

(Almost)  Everything You Need To Know About The EV Market Cover

Click the link below and we'll send you MarketBeat's guide to investing in electric vehicle technologies (EV) and which EV stocks show the most promise.

Get This Free Report
Like this article? Share it with a colleague.

Featured Articles and Offers

Recent Videos

Toyota’s Big Bet on Joby: Will Air Taxis Revolutionize Travel by 2025?
UnitedHealth Group: A Healthcare Giant with Strong Dividends
Rocket Lab’s 100% Rally: Should You Buy or Stay Cautious?

Stock Lists

All Stock Lists

Investing Tools

Calendars and Tools

Search Headlines